Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
Akorn Gets Warning Letter from FDA
April 2, 2007
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
pharmamanufacturing
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Michael Annino | Shutterstock-AI
Cell and gene therapy manufacturing challenges to persist in 2025
CDMO sector looks to recovery in 2025 amid positive macro, industry trends
Key drugs losing patent protection in 2025
Michael Annino / Shutterstock AI
Going above and beyond
Pittsburgh’s biotech leap
Michael Annino/Shutterstock AI
Pharma’s new age of longevity
Load More Content